Increased mRNA expression of Tgfb1, Acta1, Pdgfb, Timp1, and Col1a1 in the liver were observed with the progression of NAFLD (Fig. 4C–G) (P < 0.001 in Nfkbizfl/fl). This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.